Amyloid Beta and Tau as Alzheimer’s Disease Blood Biomarkers: Promise From New Technologies

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 2193-6536

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Amyloid Beta and Tau as Alzheimer’s Disease Blood Biomarkers: Promise From New Technologies ; volume:6 ; number:1 ; day:21 ; month:7 ; year:2017 ; pages:25-36 ; date:7.2017
Neurology and Therapy ; 6, Heft 1 (21.7.2017), 25-36, 7.2017

Keyword: Hirnkrankheit
Neuropsychiatrie
Nervenkrankheit

Creator: Lue, Lih-Fen

Contributor: Guerra, Andre
Walker, Douglas G.
SpringerLink (Online service)

DOI: 10.1007/s40120-017-0074-8

URN: urn:nbn:de:1111-201708264209

Rights: Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 11:00 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Lue, Lih-Fen
Guerra, Andre
Walker, Douglas G.
SpringerLink (Online service)

Other Objects (12)

Amyloid-beta and phosphorylated tau in post-mortem Alzheimer’s disease retinas

Distinct amyloid-β and tau-associated microglia profiles in Alzheimer’s disease

Diagnosis of Alzheimer’s disease utilizing amyloid and tau as fluid biomarkers

Amyloid and tau signatures of brain metabolic decline in preclinical Alzheimer’s disease

Astrocyte biomarker signatures of amyloid-β and tau pathologies in Alzheimer’s disease

CryoET of β-amyloid and tau within postmortem Alzheimer’s disease brain

Plasma brain-derived tau is an amyloid-associated neurodegeneration biomarker in Alzheimer’s disease

Astrocyte reactivity influences amyloid-β effects on tau pathology in preclinical Alzheimer’s disease

Temporal association patterns and dynamics of amyloid-β and tau in Alzheimer’s disease

Amyloid accelerates tau propagation and toxicity in a model of early Alzheimer’s disease

Hochschulschrift

Solid-state NMR characterization of Alzheimer-like tau amyloid fibrils

Non-beta-amyloid/tau cerebrospinal fluid markers inform staging and progression in Alzheimer’s disease

Amyloid-beta and phosphorylated tau in post-mortem Alzheimer’s disease retinas

Distinct amyloid-β and tau-associated microglia profiles in Alzheimer’s disease

Diagnosis of Alzheimer’s disease utilizing amyloid and tau as fluid biomarkers

Amyloid and tau signatures of brain metabolic decline in preclinical Alzheimer’s disease

Astrocyte biomarker signatures of amyloid-β and tau pathologies in Alzheimer’s disease

CryoET of β-amyloid and tau within postmortem Alzheimer’s disease brain

Plasma brain-derived tau is an amyloid-associated neurodegeneration biomarker in Alzheimer’s disease

Astrocyte reactivity influences amyloid-β effects on tau pathology in preclinical Alzheimer’s disease

Temporal association patterns and dynamics of amyloid-β and tau in Alzheimer’s disease

Amyloid accelerates tau propagation and toxicity in a model of early Alzheimer’s disease

Hochschulschrift

Solid-state NMR characterization of Alzheimer-like tau amyloid fibrils

Non-beta-amyloid/tau cerebrospinal fluid markers inform staging and progression in Alzheimer’s disease

Amyloid-beta and phosphorylated tau in post-mortem Alzheimer’s disease retinas

Distinct amyloid-β and tau-associated microglia profiles in Alzheimer’s disease

Diagnosis of Alzheimer’s disease utilizing amyloid and tau as fluid biomarkers

Amyloid and tau signatures of brain metabolic decline in preclinical Alzheimer’s disease

Astrocyte biomarker signatures of amyloid-β and tau pathologies in Alzheimer’s disease

CryoET of β-amyloid and tau within postmortem Alzheimer’s disease brain

Plasma brain-derived tau is an amyloid-associated neurodegeneration biomarker in Alzheimer’s disease

Astrocyte reactivity influences amyloid-β effects on tau pathology in preclinical Alzheimer’s disease

Temporal association patterns and dynamics of amyloid-β and tau in Alzheimer’s disease

Amyloid accelerates tau propagation and toxicity in a model of early Alzheimer’s disease

Hochschulschrift

Solid-state NMR characterization of Alzheimer-like tau amyloid fibrils

Non-beta-amyloid/tau cerebrospinal fluid markers inform staging and progression in Alzheimer’s disease

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Amyloid Beta and Tau as Alzheimer’s Disease Blood Biomarkers: Promise From New Technologies

Object Details

References and Relationships

Classification and Topics

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Amyloid-beta and phosphorylated tau in post-mortem Alzheimer’s disease retinas

Distinct amyloid-β and tau-associated microglia profiles in Alzheimer’s disease

Diagnosis of Alzheimer’s disease utilizing amyloid and tau as fluid biomarkers

Amyloid and tau signatures of brain metabolic decline in preclinical Alzheimer’s disease

Astrocyte biomarker signatures of amyloid-β and tau pathologies in Alzheimer’s disease

CryoET of β-amyloid and tau within postmortem Alzheimer’s disease brain

Plasma brain-derived tau is an amyloid-associated neurodegeneration biomarker in Alzheimer’s disease

Astrocyte reactivity influences amyloid-β effects on tau pathology in preclinical Alzheimer’s disease

Temporal association patterns and dynamics of amyloid-β and tau in Alzheimer’s disease

Amyloid accelerates tau propagation and toxicity in a model of early Alzheimer’s disease

Solid-state NMR characterization of Alzheimer-like tau amyloid fibrils

Non-beta-amyloid/tau cerebrospinal fluid markers inform staging and progression in Alzheimer’s disease

Amyloid-beta and phosphorylated tau in post-mortem Alzheimer’s disease retinas

Distinct amyloid-β and tau-associated microglia profiles in Alzheimer’s disease

Diagnosis of Alzheimer’s disease utilizing amyloid and tau as fluid biomarkers

Amyloid and tau signatures of brain metabolic decline in preclinical Alzheimer’s disease

Astrocyte biomarker signatures of amyloid-β and tau pathologies in Alzheimer’s disease

CryoET of β-amyloid and tau within postmortem Alzheimer’s disease brain

Plasma brain-derived tau is an amyloid-associated neurodegeneration biomarker in Alzheimer’s disease

Astrocyte reactivity influences amyloid-β effects on tau pathology in preclinical Alzheimer’s disease

Temporal association patterns and dynamics of amyloid-β and tau in Alzheimer’s disease

Amyloid accelerates tau propagation and toxicity in a model of early Alzheimer’s disease

Solid-state NMR characterization of Alzheimer-like tau amyloid fibrils

Non-beta-amyloid/tau cerebrospinal fluid markers inform staging and progression in Alzheimer’s disease

Amyloid-beta and phosphorylated tau in post-mortem Alzheimer’s disease retinas

Distinct amyloid-β and tau-associated microglia profiles in Alzheimer’s disease

Diagnosis of Alzheimer’s disease utilizing amyloid and tau as fluid biomarkers

Amyloid and tau signatures of brain metabolic decline in preclinical Alzheimer’s disease

Astrocyte biomarker signatures of amyloid-β and tau pathologies in Alzheimer’s disease

CryoET of β-amyloid and tau within postmortem Alzheimer’s disease brain

Plasma brain-derived tau is an amyloid-associated neurodegeneration biomarker in Alzheimer’s disease

Astrocyte reactivity influences amyloid-β effects on tau pathology in preclinical Alzheimer’s disease

Temporal association patterns and dynamics of amyloid-β and tau in Alzheimer’s disease

Amyloid accelerates tau propagation and toxicity in a model of early Alzheimer’s disease

Solid-state NMR characterization of Alzheimer-like tau amyloid fibrils

Non-beta-amyloid/tau cerebrospinal fluid markers inform staging and progression in Alzheimer’s disease

Related objects

Reset password